ACONW

Aclarion (ACONW)

Aclarion Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACONW

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	04 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACONW	Aclarion Inc
2024/04/25	22 : 14	GlobeNewswire Inc.	Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	NASDAQ:ACONW	Aclarion Inc
2024/02/28	05 : 22	GlobeNewswire Inc.	Aclarion Announces Closing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
2024/02/26	23 : 15	GlobeNewswire Inc.	Aclarion Announces Pricing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
2024/02/05	22 : 00	GlobeNewswire Inc.	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	NASDAQ:ACONW	Aclarion Inc
2024/01/22	22 : 00	GlobeNewswire Inc.	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	NASDAQ:ACONW	Aclarion Inc
2024/01/17	22 : 00	GlobeNewswire Inc.	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	NASDAQ:ACONW	Aclarion Inc
2024/01/08	22 : 00	GlobeNewswire Inc.	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
2024/01/03	02 : 00	GlobeNewswire Inc.	Aclarion Announces Reverse Stock Split	NASDAQ:ACONW	Aclarion Inc
2023/11/27	22 : 00	GlobeNewswire Inc.	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	NASDAQ:ACONW	Aclarion Inc
2023/11/08	22 : 00	GlobeNewswire Inc.	Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption	NASDAQ:ACONW	Aclarion Inc
2023/11/06	22 : 00	GlobeNewswire Inc.	Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD	NASDAQ:ACONW	Aclarion Inc
2023/11/01	21 : 00	GlobeNewswire Inc.	Aclarion Presents at the NIH HEAL Initiative Fall Meeting	NASDAQ:ACONW	Aclarion Inc
2023/10/25	21 : 30	GlobeNewswire Inc.	Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver	NASDAQ:ACONW	Aclarion Inc
2023/10/24	21 : 45	GlobeNewswire Inc.	Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting	NASDAQ:ACONW	Aclarion Inc
2023/10/23	20 : 00	GlobeNewswire Inc.	Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
2023/10/02	21 : 00	GlobeNewswire Inc.	Aclarion Provides Updated Investor Presentation and Corporate Update	NASDAQ:ACONW	Aclarion Inc
2023/08/26	05 : 10	GlobeNewswire Inc.	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report	NASDAQ:ACONW	Aclarion Inc
2023/06/15	00 : 27	GlobeNewswire Inc.	Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI	NASDAQ:ACONW	Aclarion Inc
2023/06/08	20 : 30	GlobeNewswire Inc.	Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting	NASDAQ:ACONW	Aclarion Inc
2023/05/30	20 : 30	GlobeNewswire Inc.	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic	NASDAQ:ACONW	Aclarion Inc
2023/05/23	20 : 30	GlobeNewswire Inc.	Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD	NASDAQ:ACONW	Aclarion Inc
2023/05/23	20 : 00	GlobeNewswire Inc.	Aclarion, Inc. Announces Delayed 10-Q Filing	NASDAQ:ACONW	Aclarion Inc
2023/05/19	20 : 30	GlobeNewswire Inc.	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts	NASDAQ:ACONW	Aclarion Inc
2023/05/02	20 : 00	GlobeNewswire Inc.	Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
2023/04/29	00 : 20	GlobeNewswire Inc.	Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023	NASDAQ:ACONW	Aclarion Inc
2023/04/24	20 : 00	GlobeNewswire Inc.	Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial	NASDAQ:ACONW	Aclarion Inc
2023/03/07	23 : 19	GlobeNewswire Inc.	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor	NASDAQ:ACONW	Aclarion Inc
2023/02/15	21 : 00	GlobeNewswire Inc.	Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium	NASDAQ:ACONW	Aclarion Inc